share_log

Adial Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gilliland Robertson H.

SEC ·  Mar 28 06:25
Summary by Futu AI
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction dated 03/25/2024, Robertson H. Gilliland, associated with Adial Pharmaceuticals (ADIL.US), was involved in a stock market event. The specific details regarding the nature of the transaction, such as the number of shares traded, the transaction price, and the resulting shareholding, were not disclosed. This event could be of interest to investors following Adial Pharmaceuticals, as insider transactions can provide insights into the company's financial health and future prospects.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.